|
Initially reported via the esg unified submission portal on 09/02/2026.Incorrect file type submitted with the initial report.This is a resubmission with the correct file type.On (b)(6)2026 the patient reached out directly to acclaro's clinical team.This was forwarded to acclaro qa for investigation.The patient reported fat loss under the eye as the result of ultraclear treatment.The patient reported receiving two treatments 2 days apart.The fat loss reported was noted after the second treatment.The treatments were performed on (b)(6)2026.On (b)(6)2026 the patient escalated their complaint to the clinic.The patient sought the opinion of a second dermatologist.The second dermatologist confirmed the fat loss.On 08/27/2026 acclaro qa received the following documents:
completed global impact form
email communication between the clinic and patient
patient treatment consent forms
photographs of the patient throughout treatment and healing process
on 09/01/2026 acclaro qa received a letter from the second dermatologist confirming the fat loss in the under eye and treatment with tear trough fillers.Reportability assessment was performed on 09/02/2026.
|